Top

Journal of Assisted Reproduction and Genetics

Published in:

01-06-2006 | Assisted Reproduction

Influence of the Preimplantation Embryo Development (Ped) Gene on Embryonic Platelet-Activating Factor (PAF) Levels

Authors: Elissa T. Purnell, Carol M. Warner, Hilton I. Kort, Dorothy Mitchell-Leef, Carlene W. Elsner, Daniel B. Shapiro, Joe B. Massey, William E. Roudebush

Published in: Journal of Assisted Reproduction and Genetics | Issue 6/2006

Abstract

Purpose: A major gene responsible for the control of preimplantation cleavage rate is the Ped gene, the product of which is the Qa-2 protein. Fast, but not slow developing mouse embryos express the Qa-2 protein. Platelet-activating factor (PAF) is a novel and potent signaling phospholipid that has unique pleiotropic properties in addition to platelet activation. PAF plays a significant role in virtually every reproductive event, including ovulation, fertilization, implantation, and parturition. The role of the Ped gene in PAF production by preimplantation embryos is yet to be established. The presence of this gene provides embryos with a reproductive advantage over those that are Ped negative, and may also serve as a regulator of PAF synthesis. The study hypothesis is that the amount of PAF produced is dependent upon the presence or absence of the Ped gene.

Methods: B6.K1 (Ped negative) and B6.K2 (Ped positive) mouse embryo-conditioned culture media were assayed for PAF content by a PAF-specific radioimmunoassay.

Results: There was a significant (p < 0.001) difference in blastocyst development rates between the Ped+ B6.K2 (61.0%) and the Ped− B6.K1 (25.3%) embryo culture groups. There was a significant difference (p < 0.05) in PAF production between the Ped+ B6.K2 (4.70±0.46 pmol per embryo) embryo culture group and the Ped− B6.K1 (10.02±3.49 pmol per embryo) embryo group. The B6.K1 (Ped−) embryo group produced >2× more PAF than did the B6.K2 (Ped+) group.

Conclusions: The Ped gene plays a role in PAF production and release in preimplantation stage embryos. The use of two mouse identical strains, except for the Ped gene, show that its presence is associated with an increase in developmental potential. Embryos where the Ped gene was absent produced significantly higher levels of PAF, which may aid in their survival.

Brownwell MS, Warner CM: Ped gene expression by embryos cultured in vitro. Biol Reprod 1988;39:806–811CrossRef

Streffer C, van Beuningen D, Molls M, Zamboglou N, Schulz S: Kinetics of cell proliferation in the pre-implanted mouse embryo in vivo and in vitro. Cell Tissue Kinet 1980;13(2):135–143PubMed

Dandekar PV, Glass RH: Development of mouse embryos in vitro is affected by strain and culture medium. Gamete Res 1987;17(4):279–285PubMedCrossRef

Warner CM, Brenner CA: Genetic regulation of preimplantation embryo survival. Curr Top Dev Biol 2001;52:151–192PubMed

Warner CM, Newmark JA, Comiskey M, De Fazio SR, O’Malley DM, Rajadhyaksha M, Townsend DJ, McKnight S, Roysam B, Dwyer PJ, Dimarzio CA: Genetics and imaging to assess oocyte and preimplantation embryo health. Reprod Fertil Dev 2004;16(7):729–741PubMedCrossRef

Xu Y, Jin P, Mellor AL, Warner CM: Identification of the Ped gene at the molecular level: The Q9 MHC class I transgene converts the Ped slow to the Ped fast phenotype. Biol Reprod 1994;51:695–699PubMedCrossRef

Roudebush WE: Influence of the preimplantation-embryo-development (Ped) gene on mouse blastocyst differentiation. Zool Sci 1998;15:359–362PubMedCrossRef

Wu L, Feng H, Warner CM: Identification of two major histocompatibility complex class Ib genes, Q7 and Q9, as the Ped gene in the mouse. Biol Reprod 1999;60(5):1114–9PubMedCrossRef

Goldbard SB, Warner CM: Genes affect the timing of early mouse embryo development. Biol Reprod 1982;27:424–479CrossRef

10.

Warner CM, Brownwell MS, Rothschild MF: Analysis of litter size and weight in mice differing in Ped gene phenotype and the Q region of the H-2 complex. J Reprod Immunol 1991;19:303–313PubMedCrossRef

11.

Warner CM, Panda P, Almquist CD, Xu Y: Preferential survival of mice expression the Qa-2 antigen. J Reprod Fertil 1993;99:145–147PubMedCrossRef

12.

Watkins AJ, Wilkins A, Osmond C, Warner CM, Comiskey M, Hanson M, Fleming TP: The influence of mouse Ped gene expression on postnatal development. J Physiol 2006;571:211–220

13.

Beneveniste J, Henderson PM, Cochrane CG: Leukocyte dependent histamine release from rabbit platelets: The role of Ig-E, basophils, and platelet-activating factor. J Exp Med 1972;136:1356–1376CrossRef

14.

Harper MJK: Platelet-activating factor: A paracrine factor in preimplantation stages of development? Biol Reprod 1989;40:907–913PubMedCrossRef

15.

Minhas BS, Zhu YP, Kim HN, Burwinkel TH, Ripps BA, Buster JE: Embryonic platelet-activating factor in the rabbit increases during the preimplantation phase. J Assist Reprod Genet 1993;10(5):366–370PubMedCrossRef

16.

Kikukawa Y, Ishikawa M, Sengoku K, Kasama M, Shimizu T: The effect of platelet-activating factor on ovulation. Prostaglandins 1991;42(2):95–104PubMedCrossRef

17.

Roudebush WE, Minhas BS, Ricker DD, Palmer TV, Dodson MG: Platelet-activating factor enhances in vitro fertilization of rabbit oocytes. Am J Obstet Gynecol 1993;163:1670– 1673

18.

Roberts C, O’Neill C, Wright L: Platelet-activating factor (PAF) enhances mitosis in preimplantation mouse embryos. Reprod Fertil Dev 1993;53:271–279CrossRef

19.

Ryan JP, Spinks NR, O’Neill C, Saunders DM, Wales RG: Enhanced rates of implantation and increased metabolism of mouse embryos in the presence of platelet-activating factor. Pro Fertil Soc Aust 1987;6:47

20.

Silver RK, Caplan MS, Kelly AM: Amniotic fluid platelet-activating factor (PAF) is elevated in patients with tocolytic failure and pre-term delivery. Prostaglandins 1992;43:181– 187PubMedCrossRef

21.

Collier M, O’Neill C, Ammit AJ, Saunders DM: Biochemical and pharmacological characterization of human embryo-derived platelet-activating factor. Hum Reprod 1988;3:993–998PubMed

22.

Ripps BA, Zhu YP, Burwinkel TH, Kim HN, Buster JE, Minhas BS: Platelet-activating factor production from in vitro and in vivo fertilized murine embryos is similar. Am J Reprod Immunol 1993;30:101–104PubMed

23.

O’Neill C: Partial characterization of the embryo-derived platelet-activating factor in mice. J Reprod Fertil 1985;75:375–380PubMedCrossRef

24.

Spinks NR, O’Neill C: Embryo-derived platelet-activating factor is essential for establishment of pregnancy in the mouse. Lancet 1987;1(8524):106–107PubMedCrossRef

25.

Roudebush WE, Wininger JD, Jones AE, Wright G, Toledo AA, Shapiro DB, Kort HI, Massey JB: Embryonic platelet-activating factor: An indicator of embryo viability. Hum Reprod 2002;17(5):1306–1310PubMedCrossRef

26.

O’Neill C: Autocrine mediators are required to act on the embryo by the 2-cell stage to promote normal development and survival of mouse preimplantation embryos in vitro. Biol Reprod 1998;58(5):1303–1309PubMedCrossRef

27.

Flaherty L: The Tla region of the mouse: Identification of a new serologically defined locus, Qa-2. Immunogenetics 1976;3:533–539CrossRef

28.

Ryan JP, Spinks NR, O’Neill C, Saunders DM, Ammit AJ, Wales RG: Platelet-activating factor (PAF) production by mouse embryos in vitro and its effect on embryonic metabolism. J Cell Biochem 1989;40:387–395PubMedCrossRef

29.

Wells XE, O’Neill C: Biosynthesis of platelet-activating factor by two-cell mouse embryos. J Reprod Fertil 1992;96:61–71PubMedCrossRef

30.

Goldbard SB, Verbanac KM, Warner CM: Genetic analysis of H-2 linked gene(s) affecting early mouse embryo development. J Immonogenetics 1982;9:77–82CrossRef

31.

Warner CM: Genetic manipulation of the major histocompatibility complex. J Anim Sci 1986;63:279–287PubMed

32.

Warner CM, Gollnick AO, Goldbard SB: Linkage of the preimplantation-embryo-development (Ped) gene to the mouse major histocompatibility complex (MHC). Biol Reprod 1987;36:606–610PubMedCrossRef

33.

Warner CM, Gollnick SO, Flaherty L, Goldbard SB: Analysis of Qa-2 antigen expression by preimplantation mouse embryos: Possible relationship to the preimplantation-embryo-development (Ped) gene product. Biol Reprod 1987;36:611–616PubMedCrossRef

34.

Tian Z, Xu Y, Warner CM: Removal of Qa-2 antigen alters the Ped gene phenotype of preimplantation mouse embryos. Biol Reprod 1992;47:271–276PubMedCrossRef

Title: Influence of the Preimplantation Embryo Development (Ped) Gene on Embryonic Platelet-Activating Factor (PAF) Levels
Authors: Elissa T. Purnell
Carol M. Warner
Hilton I. Kort
Dorothy Mitchell-Leef
Carlene W. Elsner
Daniel B. Shapiro
Joe B. Massey
William E. Roudebush
Publication date: 01-06-2006
Publisher: Springer US
Published in: Journal of Assisted Reproduction and Genetics / Issue 6/2006
Print ISSN: 1058-0468
Electronic ISSN: 1573-7330
DOI: https://doi.org/10.1007/s10815-006-9039-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Influence of the Preimplantation Embryo Development (Ped) Gene on Embryonic Platelet-Activating Factor (PAF) Levels

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2006

The efficacy and safety of managing ectopic pregnancies with transvaginal ultrasound-guided local injections of absolute ethanol

Human papilloma virus DNA exposure and embryo survival is stage-specific

Outcome of frozen-thawed blastocysts derived from gonadotropin releasing hormone agonist or antagonist cycles

Prenatal Diagnosis of Meckel–Gruber Syndrome in a Pregnancy Obtained With ICSI

Recurrence of hydrosalpinges after cuff neosalpingostomy in a poor prognosis population

Subclinical Pregnancy Losses Among Women Undergoing In-Vitro Fertilization With ICSI